ID

31132

Description

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00700180

Lien

https://clinicaltrials.gov/show/NCT00700180

Mots-clés

Versions (1)
  1. 21/07/2018 21/07/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

21 juillet 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Small Cell Lung Cancer NCT00700180

Anglais

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Description

Adult | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
Description

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally

Type de données

boolean

Alias
UMLS CUI [1,1]
C4288755
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2,1]
C4288304
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
>=1 measurable tumor lesion;
Description

Measurable lesion Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
ecog performance status 0-1.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy or treatment with another systemic anti-cancer agent;
Description

Prior Chemotherapy | Antineoplastic Agents Systemic

Type de données

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0003392
UMLS CUI [2,2]
C0205373
evidence of cns metastases;
Description

CNS metastases

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
history of grade 2 or higher hemoptysis;
Description

Hemoptysis CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019079
UMLS CUI [1,2]
C1516728
evidence of tumor invading or abutting major blood vessels;
Description

Tumor Invasion Blood Vessel Major

Type de données

boolean

Alias
UMLS CUI [1,1]
C1269955
UMLS CUI [1,2]
C0005847
UMLS CUI [1,3]
C0205164
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
Description

Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007131
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0553723
UMLS CUI [5,3]
C1522326
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0600139
UMLS CUI [6,3]
C0392752
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0007124
clinically significant cardiovascular disease;
Description

Cardiovascular Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
Description

Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003280
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0443225
UMLS CUI [3]
C0016018
Retour au début de la page

Similar models

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally
Item
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
boolean
C4288755 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C4288304 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
Measurable lesion Quantity
Item
>=1 measurable tumor lesion;
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | Antineoplastic Agents Systemic
Item
prior chemotherapy or treatment with another systemic anti-cancer agent;
boolean
C1514457 (UMLS CUI [1])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
CNS metastases
Item
evidence of cns metastases;
boolean
C0686377 (UMLS CUI [1])
Hemoptysis CTCAE Grades
Item
history of grade 2 or higher hemoptysis;
boolean
C0019079 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Tumor Invasion Blood Vessel Major
Item
evidence of tumor invading or abutting major blood vessels;
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS
Item
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0600139 (UMLS CUI [6,2])
C0392752 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0007124 (UMLS CUI [7,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease;
boolean
C0007222 (UMLS CUI [1])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial